SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-040679
Filing Date
2020-08-19
Accepted
2020-08-19 17:00:23
Documents
12
Period of Report
2020-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K flxn-8k_20200818.htm   iXBRL 8-K 34946
  Complete submission text file 0001564590-20-040679.txt   163713

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA flxn-20200818.xsd EX-101.SCH 5804
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20200818_lab.xml EX-101.LAB 19469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20200818_pre.xml EX-101.PRE 11651
5 EXTRACTED XBRL INSTANCE DOCUMENT flxn-8k_20200818_htm.xml XML 3555
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 201117647
SIC: 2834 Pharmaceutical Preparations